Fitusiran Approved for Hemophilia A and B

(MedPage Today) — The FDA approved fitusiran (Qfitlia) as prophylaxis to prevent or reduce bleeding episodes in adults and children ages 12 years and up with hemophilia A or B, with or without factor VIII or IX inhibitors.
“Today’s approval of…